Press Releases
InvernessMedical promotes rapid
community HIV
testing in Singapore
Determine HIV 1/2
rapid HIV test launched
For a high resolution
image please contact catherines@alto-marketing.com
Bedford, UK, 22nd October,
2007: Since August 2007, the Ministry of Health for
Singapore has made rapid HIV testing available in community clinics
across the country. In support of this new service, Inverness
Medical is promoting rapid HIV testing with informational posters
in the 125 approved clinics. Where traditional blood tests for HIV
can take days to provide results, rapid tests deliver reliable
results in as little as 15 minutes whilst the patient is still
present. Inverness Medical understands the importance of early
diagnosis in saving lives and reducing the spread of HIV infection,
and has launched Determine HIV 1/2 from the Determine STI range of
rapid diagnostic tests.
The easy to use Determine rapid test qualitatively detects for
both HIV type 1 and type 2 antibodies in human serum, plasma and
whole blood samples. Using simple, single use test cards, Determine
HIV 1/2 is ideal for use in community clinics to diagnose, monitor,
prevent and screen for HIV infection. The Determine test provides
clear visual results in just 15 minutes, making patient follow up
easier than ever before. Patient anxiety is reduced and if
necessary counselling and anti-retroviral therapy can begin with no
delay.
With around 40 million people around the world living with
AIDS/HIV1 Inverness Medical are committed to preventing
the spread of this growing epidemic. By working with the Ministry
of Health in Singapore they hope to highlight the critical role of
rapid diagnosis in the fight against AIDS/HIV worldwide.
1. World Health Organisation www.who.int/en
- Ends -
Editors Notes:
Inverness Medical Innovations is a major
global developer, manufacturer and marketer of advanced, pioneering
consumer and professional medical diagnostic products. A
leading supplier of consumer pregnancy and fertility/ovulation
tests and rapid point-of-care diagnostics, Inverness Medical
Innovations is committed to advancing health and creating
shareholder value through a continuing flow of innovative new
products brought about by our strong investment in R&D and
intellectual property. Latest areas of focus are in the application
of patented technologies to products in consumer and professional
diagnostics, principally in the fields of Cardiology, Women’s
Health, Bloodborne Pathogens and Infectious Diseases.